申请人:Boehringer Ingelheim GmbH
公开号:US03956492A1
公开(公告)日:1976-05-11
Pharmaceutical dosage unit compositions containing as an active ingredient a compound of the formula ##SPC1## Wherein R.sub.1 and R.sub.2, which may be identical to or different from each other, are each hydrogen, cycloalkyl, phenyl, --A--Y wherein A is alkyl of 1 to 5 carbon atoms or alkenyl of 1 to 5 carbon atoms, and Y is furyl, dialkylamino, hydroxyl, carbalkoxy or carbamido, Or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino, hexamethyleneimino, morpholino, thiomorpholino, thiomorpholino-S-oxide or N'-alkylpiperazino, R.sub.3 is halogen, nitro or trifluoromethyl, R.sub.4 is hydrogen, halogen or trifluoromethyl, and R.sub.5 is hydrogen, alkyl, cycloalkyl-methyl, alkylamino-alkyl, dialkylamino-alkyl or trifluoromethyl-alkyl; And a method of using the same as sedatives, tranquilizers, muscle-relaxants and anticonvulsives.
含有以下化合物作为活性成分的制药剂量单位组成物:##SPC1## 其中R.sub.1和R.sub.2可以相同也可以不同,分别是氢、环烷基、苯基、--A--Y,其中A是1至5个碳原子的烷基或1至5个碳原子的烯基,Y是呋喃基、二烷基氨基、羟基、羧基烷基或氨基甲酰基,或者与它们自己和它们所连接的氮原子一起,是吡咯烷基、哌啶基、己亚甲基亚胺基、吗啉基、硫代吗啉基、硫代吗啉-S-氧化物或N'-烷基哌嗪基,R.sub.3是卤素、硝基或三氟甲基,R.sub.4是氢、卤素或三氟甲基,R.sub.5是氢、烷基、环烷基-甲基、烷基氨基-烷基、二烷基氨基-烷基或三氟甲基-烷基;以及将其用作镇静剂、安定剂、肌肉松弛剂和抗癫痫药物的方法。